245 related articles for article (PubMed ID: 21898384)
1. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.
Maurice A; Evans DG; Affen J; Greenhalgh R; Duffy SW; Howell A
Int J Cancer; 2012 Jul; 131(2):417-25. PubMed ID: 21898384
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
4. Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
Saadatmand S; Vos JR; Hooning MJ; Oosterwijk JC; Koppert LB; de Bock GH; Ausems MG; van Asperen CJ; Aalfs CM; Gómez Garcia EB; Meijers-Heijboer H; Hoogerbrugge N; Piek M; Seynaeve C; Verhoef C; Rookus M; Tilanus-Linthorst MM;
Int J Cancer; 2014 Dec; 135(12):2940-9. PubMed ID: 24789418
[TBL] [Abstract][Full Text] [Related]
5. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
[TBL] [Abstract][Full Text] [Related]
9. Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Oudkerk M
Eur J Cancer; 2000 Mar; 36(4):514-9. PubMed ID: 10717529
[TBL] [Abstract][Full Text] [Related]
10. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
Fakkert IE; Jansen L; Meijer K; Kok T; Oosterwijk JC; Mourits MJ; de Bock GH
Breast Cancer Res Treat; 2011 Aug; 129(1):157-64. PubMed ID: 21373873
[TBL] [Abstract][Full Text] [Related]
12. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
Warner E; Plewes DB; Shumak RS; Catzavelos GC; Di Prospero LS; Yaffe MJ; Goel V; Ramsay E; Chart PL; Cole DE; Taylor GA; Cutrara M; Samuels TH; Murphy JP; Murphy JM; Narod SA
J Clin Oncol; 2001 Aug; 19(15):3524-31. PubMed ID: 11481359
[TBL] [Abstract][Full Text] [Related]
13. Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia.
Kardinah D; Anderson BO; Duggan C; Ali IA; Thomas DB
Int J Cancer; 2014 Mar; 134(5):1250-5. PubMed ID: 24037942
[TBL] [Abstract][Full Text] [Related]
14. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
15. The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.
Hettipathirana T; Macdonald C; Xie J; Moodie K; Michael C; Phillips KA
Med J Aust; 2021 Nov; 215(10):460-464. PubMed ID: 34420218
[TBL] [Abstract][Full Text] [Related]
16. MRI in the early detection of breast cancer in women with high genetic risk.
Trecate G; Vergnaghi D; Manoukian S; Bergonzi S; Scaperrotta G; Marchesini M; Ferranti C; Peissel B; Spatti G; Bohm S; Conti A; Costa C; Sporeni M; Podo F; Musumeci R
Tumori; 2006; 92(6):517-23. PubMed ID: 17260493
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
18. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V; ; Cilotti A; Di Maggio C; Fausto A; Preda L; Zuiani C; Contegiacomo A; Orlacchio A; Calabrese M; Bonomo L; Di Cesare E; Tonutti M; Panizza P; Del Maschio A
Radiology; 2007 Mar; 242(3):698-715. PubMed ID: 17244718
[TBL] [Abstract][Full Text] [Related]
19. Clinical and self breast examination remain important in the era of modern screening.
Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
[TBL] [Abstract][Full Text] [Related]
20. Clinical breast examination in a comprehensive breast cancer screening program: contribution and cost.
Feigin KN; Keating DM; Telford PM; Cohen MA
Radiology; 2006 Sep; 240(3):650-5. PubMed ID: 16926322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
